Search

Displaying results 6591 - 6600 of 8195 in total
  1. Drug

    UM-171

    go.drugbank.com/drugs/DB19449
    Investigational

    UM-171 is a pyrimidoindole derivative that is an agonist of ex vivo hematopoietic stem cell expansion and thus supports the expansion of hematopoietic stem cells.[A264868, A264873]

  2. Drug

    MaxAdFVIII

    go.drugbank.com/drugs/DB17713
    Experimental

    MaxAdFVIII is an adenoviral vector that expresses the full-length human Factor VIII (hFVIII) cDNA. First developed by GenStar, it is being investigated for the treatment of hemophilia.

  3. Drug

    Rebaudioside A

    go.drugbank.com/drugs/DB15136
    Investigational

    Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).

  4. Drug

    Bucainide

    go.drugbank.com/drugs/DB20650
    Experimental

    Bucainide has a monoisotopic molecular weight of 329.28 Da.

  5. Drug

    Cinuperone

    go.drugbank.com/drugs/DB19498
    Experimental

    Cinuperone has a monoisotopic molecular weight of 377.19 Da.

  6. Drug

    Declenperone

    go.drugbank.com/drugs/DB19700
    Experimental

    Declenperone has a monoisotopic molecular weight of 381.19 Da.

  7. Drug

    Dasantafil

    go.drugbank.com/drugs/DB19918
    Experimental

    Dasantafil has a monoisotopic molecular weight of 521.13 Da.

  8. Drug

    Embusartan

    go.drugbank.com/drugs/DB19949
    Experimental

    Embusartan has a monoisotopic molecular weight of 461.19 Da.

  9. Drug

    Tauromustine

    go.drugbank.com/drugs/DB19978
    Experimental

    Tauromustine has a monoisotopic molecular weight of 286.05 Da.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  10. Drug

    Recainam

    go.drugbank.com/drugs/DB20085
    Experimental

    Recainam has a monoisotopic molecular weight of 263.2 Da.